US Stock MarketDetailed Quotes

ACAD ACADIA Pharmaceuticals

Watchlist
  • 16.290
  • +0.080+0.49%
Close Nov 27 16:00 ET
  • 16.290
  • 0.0000.00%
Post 20:01 ET
2.71BMarket Cap20.88P/E (TTM)

ACADIA Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ACADIA Pharmaceuticals Q3 2024 Earnings Date

Currency：USDNov 6, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
248.84M
250.40M
+1.56M
Beat Est.
+17.54%
+18.28%
+0.63%
EPS
0.14
0.20
+0.06
Beat Est.
+135.08%
+150.00%
+42.55%
Analyst Rating
Strong Buy

Nov 28, 2024

ACADIA Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 233.069M--
--2024/Q4-- / 282.919M--
Nov 6, 20242024/Q3250.401M / 248.838M--
Aug 6, 20242024/Q2241.963M / 235.661M--
May 8, 20242024/Q1205.831M / 208.582M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 233.069M--
--2024/Q4-- / 282.919M--
Nov 6, 20242024/Q3250.401M / 248.838M--
Aug 6, 20242024/Q2241.963M / 235.661M--
May 8, 20242024/Q1205.831M / 208.582M--

Unlock Free Earnings Estimates

ACADIA Pharmaceuticals Earnings Reports

  • ACADIA Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 7 13:02 ET

  • ACADIA Pharmaceuticals | 8-K: Acadia Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operating Overview

    Nov 6 16:18 ET

  • ACADIA Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 7 15:13 ET

  • ACADIA Pharmaceuticals | 8-K: Acadia Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operating Overview

    Aug 6 16:21 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 28, 2024

    Strong Buy

    • Buy

      78.57%

    • Hold

      21.43%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data